Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | LOXO-260 |
Trade Name | |
Synonyms | LOXO260|LOXO 260|LOX-19260|LY3838915 |
Drug Descriptions |
LOXO-260 is a selective RET inhibitor with activity against RET solvent front and gatekeeper mutations and fusions, with potential anti-tumor activity (J of Clin Oncol 40, no. 16_suppl (June 01, 2022) TPS8595). |
DrugClasses | RET Inhibitor 53 |
CAS Registry Number | NA |
NCIT ID | C187037 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
LOXO-260 | LOXO-260 | 0 | 1 |